Influence of brain-derived neurotrophic factor and catechol O-methyl transferase polymorphisms on effects of meditation on plasma catecholamines and stress

Stress

Volumn 15, Issue 1, 2012, Pages 97-104

  Jung, Ye Ha ^b   Kang, Do Hyung ^a   Byun, Min Soo ^a   Shim, Geumsook ^a   Kwon, Soo Jin ^b   Jang, Go Eun ^b   Lee, Ul Soon ^c   An, Seung Chan ^c   Jang, Joon Hwan ^a   Kwon, Jun Soo ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Korean Institute of Brain Science   (South Korea)

Author keywords

Brain derived neurotrophic factor (BDNF); Catechol O methyl transferase (COMT); Catecholamines; Meditation; Mindbody training; Stress

Indexed keywords

ADRENALIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ANALYSIS OF COVARIANCE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE BLOOD LEVEL; FEMALE; GENOTYPE; HUMAN; MALE; MEDITATION; NORADRENALIN BLOOD LEVEL; POST HOC ANALYSIS; PRIORITY JOURNAL; STRESS;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; EPINEPHRINE; FEMALE; HUMANS; MALE; MEDITATION; METHIONINE; NOREPINEPHRINE; POLYMORPHISM, GENETIC; STRESS, PSYCHOLOGICAL; VALINE;

EID: 83455225501     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2011.592880     Document Type: Article

References (34)

1. Alexander N, Osinsky R, Schmitz A, Mueller E, Kuepper Y, Hennig J. 2010. The BDNF Val66Met polymorphism affects HPA-axis reactivity to acute stress. Psychoneuroendocrinology 35:949-953.
2. Brown J, Cooper-Kuhn CM, Kempermann G, Van Praag H, Winkler J, Gage FH, Kuhn HG. 2003. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 17:2042-2046. (Pubitemid 36713965)
3. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-Methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821. (Pubitemid 39390488)
4. Choi SM, Kang TY, Woo JM. 2006. Development and validation of a modified form of the stress response inventory for workers. J Korean Neuropsychiatr Assoc 45:541-553.
5. Cotman CW, Berchtold NC. 2002. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295-301. (Pubitemid 34667010)
6. Dusek JA, Otu HH, Wohlhueter AL, Bhasin M, Zerbini LF, Joseph MG, Benson H, Libermann TA. 2008. Genomic counter-stress changes induced by the relaxation response. PLoS One 3:e2576.
7. Glaser R, Kiecolt-Glaser JK. 2005. Stress-induced immune dysfunction: Implications for health. Nat Rev Immunol 5: 243-251. (Pubitemid 40364825)
8. Goggi J, Pullar IA, Carney SL, Bradford HF. 2003. Signalling pathways involved in the short-term potentiation of dopamine release by BDNF. Brain Res 968:156-161. (Pubitemid 36321796)
9. Infante JR, Torres-Avisbal M, Pinel P, Vallejo JA, Peran F, Gonzalez F, Contreras P, Pacheco C, Roldan A, Latre JM. 2001. Catecholamine levels in practitioners of the transcendental meditation technique. Physiol Behav 72:141-146. (Pubitemid 32184803)
10. Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, Schwartz GE. 2007. A randomized controlled trial of mindfulness meditation versus relaxation training: Effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med 33: 11-21.
11. Jones BM. 2001. Changes in cytokine production in healthy subjects practicing Guolin Qigong: A pilot study. BMC Complement Altern Med 1:8.
12. Jung YH, Kang DH, Jang JH, Park HY, Byun MS, Kwon SJ, Jang GE, Lee US, An SC, Kwon JS. 2010. The effects of mind-body training on stress reduction, positive affect, and plasma catecholamines. Neurosci Lett 479:138-142.
13. Kim SJ, Cho SJ, Jang HM, Shin J, Park PW, Lee YJ, Cho IH, Choi JE, Lee HJ. 2010. Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance. Neuropsychobiology 61: 19-26.
14. Koh KB, Park JK, Kim CH, Cho S. 2001. Development of the stress response inventory and its application in clinical practice. Psychosom Med 63:668-678. (Pubitemid 32695148)
15. Kolassa IT, Kolassa S, Ertl V, Papassotiropoulos A, De Quervain DJ. 2010. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-O-methyltransferase Val(158)Met polymorphism. Biol Psychiatry 67:304-308.
16. Koolhaas JM, Bartolomucci A, Buwalda B, de Boer SF, Flügge G, Korte SM, Meerlo P, Murison R, Olivier B, Palanza P, Richter-Levin G, Sgoifo A, Steimer T, Stiedl O, van Dijk G, Wöhr M, Fuchs E. 2011. Stress revisited: A critical evaluation of the stress concept. Neurosci Biobehav Rev 35(5):1291-1301.
17. Lapiz MD, Morilak DA. 2006. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039-1049. (Pubitemid 43053965)
18. Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, McGarvey M, Quinn BT, Dusek JA, Benson H, Rauch SL, Moore CI, Fischl B. 2005. Meditation experience is associated with increased cortical thickness. Neuroreport 16: 1893-1897. (Pubitemid 41653509)
19. Lee E, Son H. 2009. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep 42:239-244.
20. Lee J, Duan W, Mattson MP. 2002. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82: 1367-1375.
21. Lee SH, Ahn SC, Lee YJ, Choi TK, Yook KH, Suh SY. 2007. Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. J Psychosom Res 62:189-195. (Pubitemid 46161590)
22. Miller JJ, Fletcher K, Kabat-Zinn J. 1995. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry 17:192-200.
23. Mravec B. 2011. Role of catecholamine-induced activation of vagal afferent pathways in regulation of sympathoadrenal system activity: Negative feedback loop of stress response. Endocr Regul 45:37-41.
24. Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman MR. 2010. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: A preliminary study. J Alzheimers Dis 20:517-526.
25. Park YS, Ha Choi Y, Park CH, Kim KT. 2008. Nongenomic glucocorticoid effects on activity-dependent potentiation of catecholamine release in chromaffin cells. Endocrinology 149: 4921-4927.
26. Rybakowski JK. 2008. BDNF gene: Functional Val66Met polymorphism in mood disorders and schizophrenia. Pharma-cogenomics 9:1589-1593.
27. Shalev I, Lerer E, Israel S, Uzefovsky F, Gritsenko I, Mankuta D, Ebstein RP, Kaitz M. 2009. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuro-endocrinology 34:382-388.
28. Slagter HA, Lutz A, Greischar LL, Francis AD, Nieuwenhuis S, Davis JM, Davidson RJ. 2007. Mental training affects distribution of limited brain resources. PLoS Biol 5:e138.
29. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ. 2004. Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331-5335. (Pubitemid 38747674)
30. Vestergaard-Poulsen P, van Beek M, Skewes J, Bjarkam CR, Stubberup M, Bertelsen J, Roepstorff A. 2009. Long-term meditation is associated with increased gray matter density in the brain stem. Neuroreport 20:170-174.
31. Waugh CE, Dearing KF, Joormann J, Gotlib IH. 2009. Association between the catechol-O-methyltransferase Val158Met polymorphism and self-perceived social acceptance in adolescent girls. J Child Adolesc Psychopharmacol 19:395-401.
32. Xiong GL, Doraiswamy PM. 2009. Does meditation enhance cognition and brain plasticity? Ann N Y Acad Sci 1172:63-69.
33. Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP. 2010. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61:71-78.
34. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. 2003. COMT Val158Met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243. (Pubitemid 36237467)